Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Clinical trial NCT04176718 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04176718
- Sponsor
- Andrew Yee, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-18
- Primary completion
- 2027-05-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.